Search research articles
Contact Us
Filters
Showing results (771-780 of 830) with videos related to
Page
of 83
Sort By:
Ebiomedicine
|
April 19, 2020
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
Yuankai Shi, Hang Su, Yongping Song, et al.
Nature Communications
|
March 12, 2025
Proteogenomic characterization reveals tumorigenesis and progression of lung cancer manifested as subsolid nodules
Hang Su, Li Chen, Jun Wu, et al.
Science (New York, N.Y.)
|
September 1, 2012
Biogenic potassium salt particles as seeds for secondary organic aerosol in the Amazon
Christopher Pöhlker, Kenia T Wiedemann, Bärbel Sinha, et al.
Plos Pathogens
|
July 30, 2019
Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection
Xiaohua Ye, Xun Gui, Daniel C Freed, et al.
Neurosurgical Review
|
January 3, 2025
Survival and immune microenvironment prediction of glioma based on MRI imaging genomics method: a retrospective observational study
Zhihao Wang, Yunbo Yuan, Tao Cui, et al.
The Lancet. Haematology
|
January 8, 2019
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
Yuankai Shi, Hang Su, Yongping Song, et al.
Nature Communications
|
November 6, 2021
Aerosol-boundary-layer-monsoon interactions amplify semi-direct effect of biomass smoke on low cloud formation in Southeast Asia
Ke Ding, Xin Huang, Aijun Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2024
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
Yuqin Song, Zhengming Jin, Zhi-Ming Li, et al.
Signal Transduction and Targeted Therapy
|
April 16, 2024
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
Huaqing Wang, Jifeng Feng, Yanyan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 28, 2018
Strong impact of wildfires on the abundance and aging of black carbon in the lowermost stratosphere
Jeannine Ditas, Nan Ma, Yuxuan Zhang, et al.
Page
of 83
Search research articles
Search
Showing results (771-780 of 830) with videos related to
Sort By:
Page
of 83
Ebiomedicine
|
April 19, 2020
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
Yuankai Shi, Hang Su, Yongping Song, et al.
Nature Communications
|
March 12, 2025
Proteogenomic characterization reveals tumorigenesis and progression of lung cancer manifested as subsolid nodules
Hang Su, Li Chen, Jun Wu, et al.
Science (New York, N.Y.)
|
September 1, 2012
Biogenic potassium salt particles as seeds for secondary organic aerosol in the Amazon
Christopher Pöhlker, Kenia T Wiedemann, Bärbel Sinha, et al.
Plos Pathogens
|
July 30, 2019
Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection
Xiaohua Ye, Xun Gui, Daniel C Freed, et al.
Neurosurgical Review
|
January 3, 2025
Survival and immune microenvironment prediction of glioma based on MRI imaging genomics method: a retrospective observational study
Zhihao Wang, Yunbo Yuan, Tao Cui, et al.
The Lancet. Haematology
|
January 8, 2019
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
Yuankai Shi, Hang Su, Yongping Song, et al.
Nature Communications
|
November 6, 2021
Aerosol-boundary-layer-monsoon interactions amplify semi-direct effect of biomass smoke on low cloud formation in Southeast Asia
Ke Ding, Xin Huang, Aijun Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2024
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
Yuqin Song, Zhengming Jin, Zhi-Ming Li, et al.
Signal Transduction and Targeted Therapy
|
April 16, 2024
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
Huaqing Wang, Jifeng Feng, Yanyan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 28, 2018
Strong impact of wildfires on the abundance and aging of black carbon in the lowermost stratosphere
Jeannine Ditas, Nan Ma, Yuxuan Zhang, et al.
Page
of 83